| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/21/2010 | US20100017911 Viral-based transient-expression vector system for trees |
| 01/21/2010 | US20100017909 Nitrate transport components |
| 01/21/2010 | US20100017908 Highly Transformable Elite Doubled Haploid Line PH17AW |
| 01/21/2010 | US20100017907 Nucleotide sequences mediating plant male fertility and method of using same |
| 01/21/2010 | US20100017906 homozygous recessive condition of male sterility causing alleles is maintained after crossing with a second plant, that contains a restoring transgene construct having a nucleotide sequence which reverses the homozygous condition; self-fertilization |
| 01/21/2010 | US20100017905 Using expression vector comprising homozygous recessive mutation in Ms26 gene as tool in controlling fertility in plants; horticulture |
| 01/21/2010 | US20100017902 Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof |
| 01/21/2010 | US20100017900 Prostate Epithelial Androgen Receptor Suppresses Prostate Growth and Tumor Invasion |
| 01/21/2010 | US20100017894 Mutants of Human App and Their Use for the Production of Transgenice Animals |
| 01/21/2010 | US20100016588 Caffeine fraction obtained from tea leaves and a method for inducing agrobacterium tumefaciens-mediated genetic transformation in plants using said caffeine fraction |
| 01/21/2010 | US20100016572 Derived from the N-terminal domain of the serine-repeat antigen produced by the malaria parasite, Plasmodium falciparum; can be produced in Escherichia coli on a large scale by deleting all or part of polymerized serines of the 47 kd serine-repeat region; inhibit fever and cerebral malaria |
| 01/21/2010 | US20100016565 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/21/2010 | US20100016562 Reducing the immunogenicity of fusion proteins |
| 01/21/2010 | US20100016561 N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016555 N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes |
| 01/21/2010 | US20100016552 Novel hemopoietic receptor protein, NR10 |
| 01/21/2010 | US20100016549 Peyer's patch and/or m-cell targeting ligands |
| 01/21/2010 | US20100016424 Production and use of derivatized homoserine lactones |
| 01/21/2010 | US20100016415 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their use as Diagnostic Reagents and Vaccines |
| 01/21/2010 | US20100016414 Targets for human micro rnas in avian influenza virus (h5n1) genome |
| 01/21/2010 | US20100016413 Pathotropic targeted gene delivery system for cancer and other disorders |
| 01/21/2010 | US20100016411 Method of modulation of expression of epidermal growth factor receptor(egfr) involving mirna |
| 01/21/2010 | US20100016410 Methods and Compositions Related to Eosinophil Regulation |
| 01/21/2010 | US20100016409 Rna Nanoparticles and Nanotubes |
| 01/21/2010 | US20100016406 Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration |
| 01/21/2010 | US20100016405 Compositions and Methods for Inhibiting Expression of the MYC Gene |
| 01/21/2010 | US20100016359 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 01/21/2010 | US20100016241 Methods and compositions for inhibiting c-met dimerization and activation |
| 01/21/2010 | US20100016234 Signal peptides, nucleic acid molecules and methods for treatment of caries |
| 01/21/2010 | US20100016228 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/21/2010 | US20100016227 Ligand/lytic peptide compositions and methods of use |
| 01/21/2010 | US20100016221 Method of degrading protein by chaperone-mediated autophagy |
| 01/21/2010 | US20100016220 for diagnosis of a colorectal cell proliferative disease; treatment of gastric cancer or colorectal cancer |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100016177 Templated molecules and methods for using such molecules |
| 01/21/2010 | US20100016176 siRNA targeting histamine receptor H1 |
| 01/21/2010 | US20100016170 High throughput method for discovery of gene clusters |
| 01/21/2010 | US20100015707 SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION |
| 01/21/2010 | US20100015706 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof |
| 01/21/2010 | US20100015703 Antibody to mammalian cytokine-like polypeptide-10 |
| 01/21/2010 | US20100015701 Novel fluorescent proteins and methods for using same |
| 01/21/2010 | US20100015700 Use of the adenoviral e2 late promoter |
| 01/21/2010 | US20100015699 Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens |
| 01/21/2010 | US20100015698 Human Chondroitinase Glycoprotein (CHASEGP), Process for Preparing the Same, and Pharmaceutical Compositions Comprising Thereof |
| 01/21/2010 | US20100015695 Method and apparatus for amplifying nucleic acids |
| 01/21/2010 | US20100015687 Tetracycline Repressor Regulated Oncolytic Viruses |
| 01/21/2010 | US20100015681 Hydrogen Production By Means Of A Cell Expression System |
| 01/21/2010 | US20100015678 Thermophilic Organisms For Conversion of Lignocellulosic Biomass To Ethanol |
| 01/21/2010 | US20100015672 Gene Expression Cassette and a Transformant, and a Method for Manufacturing 2-Deoxy-Scyllo-Inosose and a Method for Purifying 2-Deoxy-Scyllo-Inosose Using Said Transformant |
| 01/21/2010 | US20100015671 Cyclic maltosylmaltose, cyclic maltosymaltose-forming enzyme, their preparation and uses |
| 01/21/2010 | US20100015669 Method for constructing microrna adenovirus expression plasmids of severe hepatitis related hfgl2, hfas and htnfr1 genes and pharmaceutical use thereof |
| 01/21/2010 | US20100015667 Method of in vitro polynucleotide sequences shuffling by recursive circular dna molecules fragmentation and ligation |
| 01/21/2010 | US20100015665 Antibodies and diagnostics |
| 01/21/2010 | US20100015664 Protease, dna encoding the same, and method for manufacturing protease |
| 01/21/2010 | US20100015662 Use of cellobiohydrolase from phanerochaete |
| 01/21/2010 | US20100015640 Nucleic Acid, Polypeptide and Its Use |
| 01/21/2010 | US20100015632 Method for examining colorectal cancer and colorectal adenoma |
| 01/21/2010 | US20100015627 Selection method |
| 01/21/2010 | US20100015603 Chimeric proteins for measuring atp concentrations in pericellular space and related screening method |
| 01/21/2010 | US20100015599 Isolated reductive dehalogenase genes |
| 01/21/2010 | US20100015593 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 01/21/2010 | US20100015319 Precise breeding - low acrylamide foods |
| 01/21/2010 | US20100015232 Nanoparticles for nucleic acid delivery |
| 01/21/2010 | US20100015218 Compositions and methods for potentiated activity of biologically active molecules |
| 01/21/2010 | US20100015176 Settings for recombinant adenoviral-based vaccines |
| 01/21/2010 | US20100015170 Flagellin mutant vaccine |
| 01/21/2010 | US20100015168 Immunogenic compositions for streptococcus agalactiae |
| 01/21/2010 | US20100015167 in vitro method of screening an individual for metastatic colorectal cancer cells or primary and/or metastatic stomach or esophageal cancer cells; vaccine comprising a protein that comprises human sucrase isomaltase protein |
| 01/21/2010 | US20100015163 Dendritic cell potentiation |
| 01/21/2010 | US20100015153 Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same |
| 01/21/2010 | US20100015151 Polypeptides from neisseria meningitidis |
| 01/21/2010 | US20100015150 Tdf-related compounds and analogs thereof |
| 01/21/2010 | US20100015135 Anti-ephb4 antibodies and methods using same |
| 01/21/2010 | US20100015123 Novel thrombolytic molecules and a process therefor |
| 01/21/2010 | US20100015120 Hybrid protein that converts arachidonic acid into prostacyclin |
| 01/21/2010 | US20100015117 Compositions and methods for targeting a polypeptide to the central nervous system |
| 01/21/2010 | US20100015113 Gp100-specific t cell receptors and related materials and methods of use |
| 01/21/2010 | US20100015108 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 01/21/2010 | US20100015107 Expression elements |
| 01/21/2010 | US20100015096 Fusion Proteins of Mycobacterium Tuberculosis |
| 01/21/2010 | US20100015089 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/21/2010 | US20100015087 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 01/21/2010 | US20100015056 Uranium-chelating peptides and uses thereof |
| 01/21/2010 | US20100012137 Tobacco plants having reduced nicotine demethylase activity |
| 01/21/2010 | US20100011654 Rnai for the control of insects and arachnids |
| 01/21/2010 | DE102008033381A1 Modulation der Immunantwort durch den Rezeptor NKp65 und seine Liganden Modulation of the immune response by the receptor NKp65 and its ligands |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2744265A1 Transformation of glycerol and cellulosic materials into high energy fuels |
| 01/21/2010 | CA2736311A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | CA2734279A1 Glutamate decarboxylase (gad) transgenic plants that exhibit altered plant architecture |
| 01/21/2010 | CA2734276A1 Glutamate decarboxylase (gad) transgenic plants with enhanced nitrogen uptake and utilisation |
| 01/21/2010 | CA2734274A1 Stress tolerant transgenic plants |
| 01/21/2010 | CA2731296A1 New mutated netrin 4 proteins, fragments thereof and their uses as drugs |
| 01/21/2010 | CA2731294A1 A multipurpose micro electric field networking cell processing device |
| 01/21/2010 | CA2731194A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 01/21/2010 | CA2731007A1 Method for production of reprogrammed cell using chromosomally unintegrated virus vector |
| 01/21/2010 | CA2730996A1 Long-acting interferons and derivatives thereof and methods thereof |
| 01/21/2010 | CA2730921A1 Recognition sequences for i-crei-derived meganucleases and uses thereof |
| 01/21/2010 | CA2730859A1 Brassica plant comprising a mutant indehiscent allele |